- Home
- NKSH vs BDTX Comparison
NKSH vs BDTX Comparison
Compare NKSH & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- BDTX
- Stock Information
- Founded
- NKSH 1891
- BDTX 2014
- Country
- NKSH United States
- BDTX United States
- Employees
- NKSH N/A
- BDTX N/A
- Industry
- NKSH Major Banks
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NKSH Finance
- BDTX Health Care
- Exchange
- NKSH Nasdaq
- BDTX Nasdaq
- Market Cap
- NKSH 180.8M
- BDTX 144.9M
- IPO Year
- NKSH N/A
- BDTX 2020
- Fundamental
- Price
- NKSH $29.14
- BDTX $2.20
- Analyst Decision
- NKSH Strong Buy
- BDTX Strong Buy
- Analyst Count
- NKSH 1
- BDTX 4
- Target Price
- NKSH $38.00
- BDTX $15.50
- AVG Volume (30 Days)
- NKSH 14.2K
- BDTX 1.2M
- Earning Date
- NKSH 10-24-2024
- BDTX 03-11-2025
- Dividend Yield
- NKSH 5.18%
- BDTX N/A
- EPS Growth
- NKSH N/A
- BDTX N/A
- EPS
- NKSH 1.44
- BDTX N/A
- Revenue
- NKSH $43,450,000.00
- BDTX N/A
- Revenue This Year
- NKSH N/A
- BDTX N/A
- Revenue Next Year
- NKSH $19.72
- BDTX N/A
- P/E Ratio
- NKSH $20.17
- BDTX N/A
- Revenue Growth
- NKSH N/A
- BDTX N/A
- 52 Week Low
- NKSH $26.00
- BDTX $1.91
- 52 Week High
- NKSH $35.00
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- NKSH 51.10
- BDTX 46.41
- Support Level
- NKSH $26.00
- BDTX $2.02
- Resistance Level
- NKSH $29.66
- BDTX $2.33
- Average True Range (ATR)
- NKSH 0.94
- BDTX 0.18
- MACD
- NKSH 0.18
- BDTX 0.03
- Stochastic Oscillator
- NKSH 85.79
- BDTX 38.16
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.